Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
56 Pilot study of syringe driver prescribing practice highlights challenges faced by non-palliative care teams
by
Miller, Mary
, Good, Elizabeth
, Chase, Hannah
in
Antipsychotics
/ Morphine
/ Palliative care
/ Poster Presentations
/ Psychotropic drugs
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
56 Pilot study of syringe driver prescribing practice highlights challenges faced by non-palliative care teams
by
Miller, Mary
, Good, Elizabeth
, Chase, Hannah
in
Antipsychotics
/ Morphine
/ Palliative care
/ Poster Presentations
/ Psychotropic drugs
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
56 Pilot study of syringe driver prescribing practice highlights challenges faced by non-palliative care teams
Journal Article
56 Pilot study of syringe driver prescribing practice highlights challenges faced by non-palliative care teams
2023
Request Book From Autostore
and Choose the Collection Method
Overview
BackgroundData about continuous subcutaneous infusion (CSCI) prescribing is limited.1 This survey reviewed practice in the Surgical Emergency Unit (SEU) 01.08.22 – 03.12.22, using the Pallaborative Northwest guideline.2 It aimed to determine the frequency and indication for CSCIs and to document the initial CSCI prescription.MethodsData was collected prospectively, 07.10.22 – 03.12.22 with retrospective data added to increase sample size, 01.08.22 – 06.10.22. Electronic patient records were reviewed, data anonymised, and stored on NHS drives. Data was analysed by all authors. Ethics permission was not sought as the survey examined routine practice.ResultsIn 4 months, with greater than 1000 admissions, 26 CSCIs were initiated on SEU; 1 every 5 days. The indication, documented in (31%) or determined from the notes (69%) were; dying patient 61.3%, symptom control 31%, inappropriate prescription 7.7%.All CSCIs contained opioids (73% morphine, 27% oxycodone). The median dose of morphine was 10mg/24 hours (IQR 10mg/24 hours), the median dose of oxycodone was 7.5 mg/24 hours (IQR 10mg/24 hours).65% of CSCI contained an antiemetic (35% metoclopramide, 23.5% haloperidol, 41% cyclizine), 8% an antisecretory/antispasmodic agent (100% hyoscine butylbromide) and 50% an anxiolytic/antipsychotic (69% midazolam and 31% haloperidol).77% of CSCIs were advised by the hospital palliative care team (HPCT). Of the other 23%, half were altered or discontinued because of concerns; CSCI not indicated, patient sedated, or concern about dose.Commencing a CSCI was discussed with 23% of patients and 42% of families.ConclusionCSCI prescribing on SEU is an infrequent event. Staff need support from HPCTs to guide initiation and medication doses. Initiation of a CSCI provides an opportunity to explore patient and family understanding and involve them in conversations about care. Learning will be fed back to SEU and hospital staff. Further larger scale data collection is planned in deanery to interrogate practice.2
Publisher
British Medical Journal Publishing Group,BMJ Publishing Group LTD
Subject
MBRLCatalogueRelatedBooks
This website uses cookies to ensure you get the best experience on our website.